Lynne Peeples | Authors

ASCO: An Epidemic of Contralateral Prophylactic Mastectomy

June 13, 2011

While overall mastectomy rates have dropped in recent years, more and more women with cancer in one breast are opting to have both breasts removed. The trend has left many researchers questioning whether contralateral prophylactic mastectomy (CPM) is getting overused, or if it simply reflects a better recognition by both patients and physicians of who is likely to develop breast cancer.

ASCO 2011: Better Knowledge, Better Treatments in Myelodysplatic Syndromes

June 08, 2011

A growing understanding of the biology behind myelodysplastic syndromes (MDS) is leading the way to improved treatment options, according to two presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

ASCO 2011: New Hope for Metastatic Melanoma

June 06, 2011

Metastatic melanoma maintains a growing presence around the world, and a steady disregard for treatment efforts. But two novel drugs presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, on Sunday, suggest that medicine might finally be ready to fight back against the deadliest form of skin cancer.

ASCO: Emerging Biomarkers in Triple-Negative Breast Cancer

June 05, 2011

Triple-negative breast cancer (TNBC) continues to carry a poor prognosis. However, novel prognostic and potentially predictive biomarkers may soon improve that bleak outlook, according to a series of studies presented on Saturday at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Avoiding the Under- and Over-treatment of Breast Cancer in the Elderly

March 14, 2011

Dr. Muss and his colleagues investigated the use of adjuvant chemotherapy in patients with lymph node-positive breast cancer to determine if older people got the same "bang for the buck" as younger people when given more aggressive modern regimens.

Breast Cancer "Practice Changers" From San Antonio and ASCO

March 10, 2011

Rapid advances in the prevention, diagnosis and treatment of breast cancer keep clinicians on their toes. And this last year offered no reprieve, according to Debu Tripathy, MD, who highlighted several recent shifts and refinements to practice in his talk at the Miami Breast Cancer Conference.